Brief: MGC Pharmaceuticals Announces Positive Pre-Clinical Trial Results On Cimetra

Argent BioPharma

14/08/2023 07:10

Aug 14 (Reuters) - MGC Pharmaceuticals Ltd  MXC.AX :
    * MGC PHARMACEUTICALS   - POSITIVE PRE-CLINICAL TRIAL
RESULTS ON
CIMETRA®
    * MGC PHARMACEUTICALS LTD - POSITIVE PRE-CLINICAL TRIAL
RESULTS
FROM PRE-CLINICAL CHRONIC TOXICOLOGY EVALUATION OF 14 DAYS ORAL
DOSE OF CIMETRA
    * MGC PHARMACEUTICALS LTD - STUDY FOUND FOLLOWING FULL
CHRONIC
SAFETY AND TOXICOLOGY ANALYSIS OF CIMETRA IN LARGE ANIMALS -
DRUG WAS FOUND TO BE SAFE
    * MGC PHARMACEUTICALS LTD - IND SUBMISSION IS PLANNED FOR Q1
2024
FOR CIMETRA

Source text for Eikon:  ID:nRSN2017Ja 
Further company coverage:  MXC.AX 

 ((Reuters.Briefs@thomsonreuters.com;))